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Abstract
G-Protein Coupled Receptors (GPCRs) are key players in cell-
cell communication. They transduce a wide range of extracellular
signals such as light, odors, hormones or neurotransmitters into ap-
propriated cellular responses. These receptors regulate many cell
functions and are encoded by the largest gene family in mammalian
genomes, representing more than 3% of the human genes. GPCRs
are the estimated target of approximately half of the medicines cur-
rently in clinical use.
Probabilistic modelling and specifically, machine learning prob-
abilistic models have only recently begun to be applied to the anal-
ysis of GPCR functioning, although their application is expected
to generate new insights in this field. Statistical machine learning
techniques are specially suited to deal with some of the common
challenges of molecular modelling in proteins, and should be of spe-
cial interest when the three dimensional structures of the proteins
and receptors remain unknown at large.
In this thesis, we describe a statistical machine learning model
of the manifold learning family, adapted through kernelization to
the analysis of protein sequence data. Experimental results show
that it provides a differentiated visualization and grouping of GPCR
subfamilies and that these groupings faithfully reflect the structure
of GPCR phylogenetic trees.
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Chapter 1
Introduction
It has been just over 10 years since the publication of the first draft of the
human genome decoding [39]. The detailed description of the human genome is
a milestone of science in general and of medicine in particular. It has opened
the doors to new approaches to investigate pathologies that hold the promise of
the advent of truly personalized medicine. Through these doors, though, a new
challenge for intelligent data analysis has also entered.
Over the last decade, medicine has become a data-intensive area of research.
One in which new data-acquisition technologies and a wider variety of investiga-
tive goals coalesce to make it one of the most important challenges for intelligent
data analysis [36]. The -omics sciences have contributed the most to this data
deluge, stemming from microarrays in genomics, from protein chips and tissue
arrays in proteomics, etc. As very explicitly reported in [29] [...] the need to
process terabytes of information has become de rigueur for many labs engaged
in genomic research.
Arguably, drug research has contributed more to the progress of medicine
during the past century than any other scientific factor [12]. One of the main
areas of drug research deals with the analysis of proteins. The function of the
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proteins depends directly on their 3D structure, which is embodied in their
amino acid sequence. Such 3D structure is difficult to unravel, but protein
sequences are easy to acquire. The analysis of the gene-family distribution of
targets by drug substance reveals that more than 50% of drugs target only
four key gene families, from which almost a 30% correspond to the GPCRs
superfamily [42]. This superfamily regulates the function of most cells in living
organisms and is the focus of the work reported herein. The grouping of GPCRs
into families or classes and these into types and subtypes based on sequence
analysis may significantly contribute to helping drug design and to a better
understanding of the molecular processes involved in receptor signalling both in
normal and pathological conditions.
The challenge of managing the complexity of these types of data invites
us to go one step further than traditional statistics and resort to intelligent
pattern recognition approaches. In particular, statistical pattern recognition
and machine learning methods bear the potential to both to scale well to large
databases and to deal with non-trivial types of data. Sound statistical principles
are essential to trust the evidence base built with any computational analysis of
medical data [35]. Statistical machine learning methods are already establishing
themselves in the more general field of bioinformatics [2].
The motivation of this thesis is the need for a robust probabilistic method
capable of grouping and visualizing symbolic protein sequences, based on their
structural and functional properties. As mentioned in [55], there is no biologically-
relevant manner of representing the symbolic sequences describing proteins us-
ing real-valued vectors. This does not preclude the possibility of assessing the
similarity between such sequences. Kernel methods can be used to this pur-
pose if understood as similarity measures. Moreover, the visualization of high-
dimensional protein sequence data can be the key exploratory tool for finding
meaningful information that might be obscured by the intrinsic complexity of
data [7].
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In this thesis, the analysed data consist of sequences of GPCRs. These
proteins were selected because an enormous amount of current pharmaceutical
research is aimed at understanding their structure and function. They play an
important role in human physiology and disease, but their three-dimensional
structures remain mostly unsolved.
The following chapters report work on the grouping and visualization of
GPCR protein sequences using a kernel variant of a non-linear model of the
manifold learning family. A suitable kernel for this type of data is described.
The visualization of the sequence data and the grouping results can be a useful
tool in the quest for interpretability. The reported results reinforce the veracity
of this statement.
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Chapter 2
The biological problem
2.1 Current targets in the quest for new medicines
As stated in [42], there is a paradox in the fact that an industry such as pharma
that spends yearly more than US $50 billion on R+D, has not been able to
generate enough knowledge about the set of molecular targets that are the
object of its products. That is why drug target discovery has, of late, received
much attention from different areas of biochemistry-related drug research.
Arguably, drug research has contributed more to the progress of medicine
in the past century than any other factor [12]. This is the result of advances
in chemistry, pharmacology, and the clinical sciences. Molecular biology and
genomics are now at the forefront of drug research. This has been exponentially
amplified by developments in information, communication, and computation
technologies. Genomics, proteomics, and the bioinformatics tools that support
them can provide us with knowledge of suitable targets for medicines yet to be
designed and, therefore, with a more proactive leverage on the process of drug
design.
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2.1.1 Receptors
Briefly, receptors can be defined in biochemistry as proteins to which signalling
molecules may attach. They can be divided into two classes: the membrane-
bound receptors and the soluble cytoplasmic or nuclear receptors. Receptors
constitute the first step in the process of external signalling allowing the initia-
tion of intracellular signalling cascades after specific ligand binding.
This thesis focuses on GPCRs, a particular set of membrane-bound recep-
tors. GPCRs, as indicated by their name, signal through their interaction and
subsequent activation of G proteins [22]. However, the functioning of these
receptors appears more complex than was initially thought and additional ac-
cessory proteins play a role in the signal transduction concert. Proteins other
than G proteins reported to interact with GPCRs and potentially responsible
for G protein-independent GPCR signalling include β-arrestins, tyrosine kinases
and PDZ-domain containing proteins [51]. Nevertheless, discussion on GPCR
signalling pathways other than G proteins is beyond the scope of the present
work and will not be included here.
2.1.2 GPCRs as pharmacological targets
GPCRs constitute the most abundant family of membrane-bound receptors and
one of the largest in the whole human genome [46]. Analysis of the gene-family
distribution of targets by drug substance reveals that more than 50% of drugs
target only four key gene families, from which almost a 30% correspond to
the GPCR superfamily. GPCRs regulate the function of most cells in living
organisms.
GPCRs have been the subject of a vast research effort in the pharmaceutical
industry due to their ubiquity and involvement in a broad spectrum of physio-
logical functions. Moreover, drugs do not need to have the ability to cross the
cell membrane to stimulate these receptors, thus increasing the size of the drug
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discovery space and the possibility of success. Some examples of therapeutic
indications for drugs acting on GPCRs are: antihistamines, anaesthetics, an-
tidepressants, antipsychotics, anxiolytics, anti-ulcer, hypertension controllers,
asthma, heart failure, Parkinson’s, schizophrenia, migraines and cancer.
In this thesis, we have paid special attention to metabotropic glutamate
receptors (mGlu receptors), a type of receptors belonging to GPCR family C
that has generated a wealth of publications over the last few years (a search of
the mGlu receptor string in PubMed 1 on 13th June 2011 produced 63 references
for the year 2011), which shows that these receptors are very attractive as
a pharmacological target for innovative drugs in neurological and psychiatric
disorders.
2.2 GPCRs: Structure, function and classifica-
tion
GPCRs consist of a single protein chain that crosses the membrane seven times
[26]. For this reason they are also known as seven transmembrane (or 7TM)
receptors. They constitute the most abundant family of membrane receptors
and one of the largest in the whole human genome [46]. As mentioned previously,
the name is derived from their association with heterotrimeric G proteins, which
act as intermediary components, activating or inhibiting several intracellular
effectors.
GPCRs were discovered in 1970 by Martin Robdell who determined the
link between the activity of glucagon peptide and a molecule called guanosine
triphosphate (GTP). At the same time, Alfred G. Gilman corroborated these
results by finding the same trend in adrenergic receptors. The molecule respon-
sible for the signal transduction was called G-protein [22]. These discoveries
1http://www.ncbi.nlm.nih.gov/pubmed/
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allowed both researchers to share the Nobel Prize in 1994.
Figure 2.1: General structure of a GPCR protein
All GPCRs share a common general protein structure. The seven trans-
membrane helices are connected between them by three intracellular and three
extracellular loops with varying lengths for each receptor subtype. The hepta-
helical transmembrane domain is largely hydrophobic, whereas the extracellular
and intracellular segments, or loops, are generally hydrophilic. GPCRs have an
extracellular amino terminus and an intracellular carboxyl terminus (See figure
2.1 courtesy of URL2). The most variable structures among the family of GPCRs
are the carboxyl terminus, the intracellular loops and the amino terminus (See
figure 2.2).
The ligands that bind and activate these receptors include light-sensitive
compounds, various sensory signals (such as light and odors), pheromones, hor-
mones, and neurotransmitters, and vary in size from small molecules to pep-
tides, and to large proteins. Their stimulation leads to activation of specific
2http://www.csuci.edu/alzheimer/science/
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G-proteins that transduce extracellular mediator messages to specific intracel-
lular signalling pathways, producing particular cellular responses. In general,
they can be thought as a communication tool between the cell and the outside
world.
Figure 2.2: Structural diversity of GPCRs: family A, family B and family C
[10]
The GPCRDB3 [26], a database system for GPCRs, divides the GPCR su-
perfamily into five major families (A to E) based on the ligand types, functions,
and sequence similarities (summarized in table 2.1). Within the families, pro-
teins are further divided into groups (types and subtypes) which bind common
agents on the extracellular side of the membrane. The evolutionary relationship
between groups is not known; they may have diverged from a common ancestor
or be the result of convergent evolution, in which functional constraints lead to
unrelated proteins from different organisms with the same design.
The sequences of different GPCR families are highly diverged from each
other, except that they share one common structural feature, that is, they all
have seven hydrophobic transmembrane regions. GPCRs within a family share
common functions and more sequence similarities. Family A, the Rhodopsin like
class, is by far the most populated GPCR family with more than 3,500 mem-
bers in the database. Each family is further divided into groups, and so forth,
3http://www.gpcr.org/7tm/
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Superfamily Description
Family A Receptors related to Rhodopsin and the beta2-adrenergic Receptors
Family B Receptors related to the Calcitonin and PTH/PTHrP Receptors
Family C Receptors related to the Metabotropic Receptors
Family D Receptors related to the pheromone Receptors
Family E Receptors related to the cAMP Receptors
Table 2.1: G-protein coupled receptor families
depending upon the common agents they bind to and sequence similarities.
While the identification of the function of GPCR sequences has a great im-
portance in biomedical and pharmaceutical research, identifying and classifying
this membrane protein superfamily is a difficult task due to the high levels of
divergence observed among the GPCR family members. Therefore, it becomes
important that there be a way to accurately and efficiently identify any new
GPCRs from genomic data. As a consequence, this would benefit the phar-
maceutical research and give us a better understanding of GPCR functions.
GPCRs are used in this study due to their scientific importance, and also as an
example of highly diverged protein families.
2.3 GPCR Family C
The family C of GPCRs have become an increasingly important target for new
therapies, particularly in areas such as pain, anxiety, neurodegenerative disor-
ders and as antispasmodics, but also potentially for the treatment of hyperthy-
roidism and osteoporosis.
In contrast to other GPCRs families, family C receptors are composed of
three main structural domains, not including the C-terminal tail which can
be very long and where a multitude of intracellular scaffolding and signaling
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molecules bind. These domains are the Venus flytrap (VFT), which contains the
agonist binding site (orthosteric site), the cysteine-rich domain (CRD) and the
heptahelical domain (HD) involved in G-protein activation (See figure 2.3), and
which contains potential allosteric sites to which synthetic allosteric ligands may
bind. In addition, family C GPCRs have been shown to be constitutive dimers
and therefore represent a good model for studying the functional relevance of
GPCR dimerization [3].
Figure 2.3: mGlu receptors are grouped into three families: group I, group II,
and group III. [28]
Seven types of Family C, summarized in table 2.2, were investigated in this
thesis, namely: Metabotropic glutamate, Calcium sensing, GABA-B, Vomeronasal,
Pheromone, Odorant and Taste.
20
GPCR Family C Description
Type 1 Metabotropic glutamate
Type 2 Calcium sensing
Type 4 GABA-B
Type 5 Vomeronasal
Type 6 Pheromone
Type 7 Odorant
Type 8 Taste
Table 2.2: GPCR Family C types
2.3.1 Metabotropic glutamate receptors
The metabotropic glutamate (mGlu) receptors, which belong to the first group
of the GPCR Family C, are activated by glutamate, the major excitatory neuro-
transmitter in the central nervous system, and play important roles in regulat-
ing cell excitability and synaptic transmission. The mGlu receptors are widely
distributed throughout the central nervous system, and a whole range of neuro-
logical and psychiatric disorders might be treated using drugs that act directly
on these receptors.
There are eight types of mGlu receptors (eight genes encoding for mGlu1
to mGlu8 in humans) divided into three groups (See figure 2.3) according to
structure, pharmacology and mechanism of signal transduction [50]:
• Group-I: mGlu1,mGlu5
• Group-II: mGlu2,mGlu3
• Group-III: mGlu4, mGlu6, mGlu7 and mGlu8
Like other components of the glutamatergic system, mGlu receptors also
have a widespread distribution outside the CNS, including cells that do not have
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Figure 2.4: Summary of roles of mGlu receptors in peripheral tissues [28]
a neuronal phenotype (See figure 2.4). Analysis of the recent literature reveals
an extraordinary potential, particularly for groups I and III, in the treatment of
peripheral disorders of the most diverse nature, such as endocrine dysregulation,
aberrant cell proliferation, and gastrointestinal disorders [28]. The significance
of these findings is that pharmacological tools originally designed for mGlu
receptors in the CNS may also be directed toward new disease targets in the
periphery.
The wide diversity and heterogeneous distribution of mGlu subtypes provides
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an opportunity for selectively targeting individual mGlu subtypes involved in
only one or a limited number of CNS functions for the development of novel
treatment strategies for psychiatric and neurological disorders. A large body
of preclinical studies now suggests that ligands for specific mGlu subtypes have
potential for the treatment of multiple CNS disorders, including depression,
anxiety disorders, schizophrenia, pain syndromes, epilepsy, Alzheimer’s disease,
and Parkinson’s disease, among others.
2.4 From the amino acid sequence to the struc-
ture and function of the protein
The function of the proteins depends directly on their 3D structure, which
is embodied in their amino acid sequence. GPCRs are membrane proteins,
and this environment makes their 3D structure difficult to unravel through nu-
clear magnetic resonance or X-ray crystallography. Knowledge about the three-
dimensional structure of a GPCR is crucial for the understanding of its function
and for the design of drugs. Modern molecular biology methods, though, make
their amino acid sequences easy to acquire. The grouping of GPCRs into types
and subtypes based on sequence analysis may significantly contribute to helping
drug design and to a better understanding of the molecular processes involved
in receptor signaling both in normal and pathological conditions [9].
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Chapter 3
Analyzing Protein
Sequences using Kernel
Methods
The task of protein grouping, where proteins are specified by their amino acid
sequences, aims to find biologically meaningful partitions of a given protein
family. This might help the analyst to make inferences about key protein regions
and residues both in the obtained groups and for the whole family. In order to
get a better understanding of the functional role of the members of a protein
family in biochemical processes, it is important to know the internal organization
of the family and to detect key regions where interactions with other molecules
may take place or which are essential to inform the three-dimensional structure
of the protein.
The grouping of GPCRs into types and subtypes based on sequence analysis
may significantly contribute to helping drug design and to a better understand-
ing of the molecular processes involved in receptor signalling both in normal
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and pathological conditions [28]. The importance of the GPCR as physiolog-
ical agents and drug targets more than justifies our efforts in addressing this
challenge.
In order to group GPCR sequences, we need a measure of similarity be-
tween them. Pattern recognition and machine learning techniques can help us
in this task. Unsupervised data analysis using clustering algorithms provides a
useful tool to explore data structures. Broadly speaking, the aim of clustering
methods is that of grouping patterns on the basis of similarity (or dissimilarity)
criteria, where the resulting groups or clusters are data subsets including similar
patterns.
Unsupervised methods that were capable of providing simultaneous grouping
and visualization of sequence data would be especially adequate for this type
of problem, as visualization can help us to intuitively interpret the grouping
and classification results by providing intuitive insights about the relationships
between groups. The visualization of the high-dimensional GPCR sequences
would considerably help to understand their global grouping structure.
The visualization of data clusters in low-dimensional spaces also becomes a
dimensionality reduction task, for which linear and nonlinear modeling strate-
gies can be used. Most of this strategies, though, have been designed for real-
valued data. Needless to say, protein symbolic sequences of amino acids do
not fit into this description, and alternative strategies are thus required. In
this thesis, we resort to kernel methods. Over the last few years, several ker-
nel methods for the visualization (and eventually clustering) of non-standard
multivariate data have been proposed. The use of kernels allows mapping data
implicitly into a high-dimensional space called feature space, in such a way that
computing a linear partitioning in this feature space results in a corresponding
nonlinear partitioning in the observed data space.
In the remaining of this chapter, we describe the basis of two of these meth-
ods that we consider to be representative of the current available choices in the
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field. They should help to lay the conceptual foundations of the kernel manifold
learning model used in this thesis, which is described in some detail in the next
chapter.
3.1 Kernel Principal Component Analysis
Principal Component Analysis (PCA) [45] is an orthogonal transformation of
the coordinate system in which we describe the observed multivariate data.
The new coordinate system is obtained by projection onto the so-called prin-
cipal axes of the data. The central idea of PCA is to achieve dimensionality
reduction while retaining as much of the variation present in the data set as
possible. Dimensionality reduction is achieved because a small number of prin-
cipal components often suffices to account for most of the variance (structure)
in the data.
This transformation yields a new set of variables or features (PCA can be
classified as a feature extraction technique), known as principal components
(PCs), which are uncorrelated, and which can be ordered so that the first few
retain most of the variation present in all of the original variables. PCA takes
an initial subset of these features and projects the observed data into the space
it spans.
Data are effectively transformed by projecting them into the subspace spanned
by the first k eigenvectors of the covariance matrix of the analyzed data set. The
new coordinates are known as the principal coordinates with the eigenvectors re-
ferred to as the principal axes. Details of this technique can be found elsewhere
[27].
Kernel PCA [53], or KPCA, is the application of PCA in a kernel-defined
feature space making use of the dual representation. This method makes possi-
ble to detect nonlinear relations between variables in the data by embedding the
data into a kernel-induced feature space, where linear relations can be found by
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means of PCA. Also, KPCA can be seen as a way of inferring a low-dimensional
explicit geometric feature space that best captures the structure of the data.
The projection of a new data point φ (x) onto the direction uj in the feature
space, is given by
Puj (φ (x)) = u
′
jφ (x) =
〈
l∑
i=1
α
j
iφ (xi) , φ (x)
〉
(3.1)
=
l∑
i=1
α
j
i 〈φ (xi) , φ (x)〉 =
l∑
i=1
α
j
iK (xi, x) (3.2)
Hence, we will be able to project new data onto the eigenvectors in the feature
space by performing an eigen-decomposition of the kernel matrix.
Let be Uk the subspace spanned by the first k eigenvectors in the feature
space. Then, we can compute the k-dimensional vector projection of new data
into this subspace as
PUk (φ (x)) =
(
u′jφj (x)
)k
j=1
=
(
l∑
i=1
α
j
iK (xi, x)
)k
j=1
(3.3)
where αj = λ
− 1
2
j vj is given in terms of the corresponding eigenvector λj and
eigenvalue vj of the kernel matrix. Equation 3.3 forms the basis of KPCA.
The critical question for assessing the performance of KPCA is the extent to
which the projection captures new data drawn according to the same distribu-
tion as the training data. Therefore, we assess the stability of KPCA through
the pattern function:
f(x) =‖ P⊥Uk (φ (x)) ‖
2=‖ φ (x)− PUk (φ (x)) ‖
2=
‖ φ (x) ‖2 − ‖ PUk (φ (x)) ‖
2
That is, the squared norm of the orthogonal (residual) projection for the sub-
space Uk spanned by the first k eigenvectors. As always we wish the expected
value of the pattern function to be small
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EX [f (x)] = EX
[
‖ P⊥Uk (φ (x)) ‖
2
]
≈ 0
Thus, capturing a high proportion of the data variance in an small number
of dimensions is an indication that a reliable set of features has been detected
and that the corresponding subspace will capture most of the variance of yet
unobserved test data.
3.2 Kernel Self-Organizing Maps
KPCA provides a method according to which we can visualize GPCR sequences
in a representation space (e.g. spanning only two PCs). Unfortunately, this
visualization through projection is not accompanied by a grouping or clustering
of the sequences. The Self-Organizing Map (SOM), popularly referred to as
Kohonen network [31], [30] is a computational intelligence method for the visu-
alization of high-dimensional data that also provides vector quantization and,
in doing so, allows the partition of the data into clusters.
The SOM defines an topologically-ordered mapping that generates the pro-
jection of observedmultivariate data items onto a regular, usually two-dimensional
map. This map consists of a regular lattice of processing units, also called neu-
rons (due to the original description of SOM as a bio-plausible model of cogni-
tive processes). Each of these units is associated to a prototype vector in the
observed data space, which can be considered as a representative example of
a given subset of data cases. The map attempts to represent all the available
data cases with optimal accuracy using a restricted set of prototypes. Each
prototype could therefore be understood as a cluster representative.
The resulting map is meant to retain the topological order of the observed
space, so that similar prototypes in the observed space are also close to each
other in the visualization map.
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In its standard form, the SOM algorithm distinguishes two stages: the com-
petitive stage and the cooperative stage. In the former, the SOM neuron best
matching a given data case is selected, while, in the latter, the coefficients (or
weights) of the best-matching prototype (and to a lesser extent, those of its
immediate lattice neighbors) are changed to become fractionally closer to that
data case.
More formally, let X = [x1, x2, ...xd]
T ∈ Rd be the input vector. Assume
a discrete lattice of units indexed with a index i. Each unit is associated to a
corresponding weight vector (prototype) W = [w1, w2, ...wd]
T ∈ Rd. Data case
Xn is mapped to that unit whose weight vector is its nearest neighbour, from
among all the weight vectors. This is called the best-matching unit(BMU) and
is found as: BMUn = argmini‖Xn −Wi‖
Thus, the training process of the SOM algorithm can be summarized as
follows:
• For each observed data case, find out the nearest-neighbour (winner) from
among the weight vectors associated to the map.
• Update the weights of the winner and all its neighbours according to some
updating criterion.
• Iterate the process for all data cases (in an online or batch procedure)
until some convergence criterion is met.
The SOM model, though, has some limitations due to its heuristic nature.
In summary:
• Different runs of the SOM algorithm with different initializations yield
different results.
• The selection of its parameters (e.g., learning rate, or neighbourhood func-
tion type or size) has no theoretical basis.
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• There is no guarantee of error convergence for the training procedure.
Neighbourhood preservation is not guaranteed either.
• There is no theoretical basis for complexity control (regularization and
overfitting)
Furthermore, the Euclidean distance used to describe similarity in the stan-
dard SOM model is not adequate for the analysis of non-real-valued data such
as symbolic protein sequences.
Recently, a kernel version of the SOM, namely the Kernel Self-Organizing
Map, or KSOM, was proposed by MacDonald and Fyfe [37]. It can be under-
stood as a kernelization of the k-means clustering algorithm, but with added
neighbourhood learning. More precisely, a kernel function is applied to trans-
form the input (observed data) into a high-dimensional feature space, thus
transforming the distance metric to nonlinear and adding more flexibility in
the vector-quantization process in order to better capture the data structure
[33]. Each data case x is mapped to the feature space via a nonlinear func-
tion φ (x). In principle each mean can be described as a weighted sum of the
observations in the feature space,
mi =
∑
n
γi,nφ (xn)
where {γi,n} are the constructing coefficients. The algorithm then selects a
mean or assigns a data case with the minimum distance between the mapped
point and the mean,
‖φ (x)−mi‖
2 =‖ φ (x)−
∑
n
γi,nφ (xn) ‖
2= (3.4)
K (x, x)− 2
∑
γi,nK (x, xn) +
∑
n,m
γm,nK (xn, xm) (3.5)
The update of the mean is based on an update expression similar to that of
the SOM:
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mi (t+ 1) = mi (t) + Λ [φ (x)−mi (t)] (3.6)
where Λ is the normalized winning frequency of the i-th mean, defined as:
Λ =
ξi(x),j∑t+1
n=1 ξi,n
(3.7)
and ξ is the winning counter and is often defined as a Gaussian function between
the indexes of the two neurons. As the mapping function φ is not known, the
updating rule 3.6 is further elaborated and leads to the following updating rules
for the constructing coefficients of the means [37]:
γi,n (t+ 1) =


γi,n (t) (1− ξ) , for n 6= t+ 1
ξ, for n = t+ 1
Note that these constructing coefficients, γi,n, together with the kernel func-
tion, effectively define the kernel SOM in the feature space. The winner selec-
tion, i.e. 3.4, operates on these coefficients and the kernel function. No explicit
mapping function φ is required. The exact means or neuron weights mi, are not
required [62].
There is an alternative direct way to kernelize the SOM by mapping the data
points and neuron weights, both defined in the input space, to a feature space;
this is followed by applying standard SOM in the mapped dot-product space.
The winning rules of this second type of KSOM have been proposed as follows,
either in the input space [44], v = argmin
i
‖x −mi‖ or in the feature space [1],
v = argmin
i
‖φ (x) − φ (mi) ‖
These two rules are equivalent for certain kernels, such as the Gaussian. The
weight update rule proposed in [1] is:
mi (t+ 1) = mi (t) + α (t) η (v (x) , i)∇J (x,mi) (3.8)
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where ∇J (x,mi) = ‖φ (x) − φ (mi) ‖
2 is the distance function in the feature
space or the proposed instantaneous or sample objective function. Also, α (t)
and η (v (x) , i) are, in turn, the learning rate and neighbourhood function.
Note that,
J (x,mi) = ‖φ (x)− φ (mi) ‖
2 = K (x, x) +K (mi,mi)− 2K (x,mi)
and,
∇J (x,mi) =
∂K (mi,mi)
∂mi
− 2
∂K (x,mi)
∂mi
Therefore this kernel SOM can also be operated entirely in the feature space
with the kernel function. As the weights of the neurons are defined in the input
space, they can be explicitly resolved.
The standard SOM minimizes the following energy function [32], [25]:
E =
∑
i
∫
Vi
∑
j
η (i, j) ‖ x−mj‖
2p (x) dx
where Vi is the Voronoi region of neuron i.
The extension of this energy function in the feature space is:
EF =
∑
i
∫
Vi
∑
j
η (i, j) ‖ φ (x) − φ (mj) ‖
2p (x) dx
The KSOM can be seen as a result of directly minimizing this transformed
energy. Using the sample gradient on η (v (x) , j) ‖ φ (x)− φ (mj) ‖
2, we obtain:
∂EˆF
∂mi
=
∂
∂mj
∑
j
η (v (x) , j) ‖ φ (x)− φ (mj) ‖
2 = −2η (v (x) , i)∇J (x,mj) ,
which leads to the same weight update expression for the KSOM as in equation
3.8.
Although KSOM makes the standard Kohonen map much more flexible, it
still inherits the limitations of SOM outlined above. The analysis of GPCR
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sequences would benefit from a model with solid grounds on probability theory
that might benefit from the automatic optimization of all its parameters. One
such kernel model of the manifold learning family is proposed and applied to
the analysis of GPCR sequences in the following chapter.
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Chapter 4
Grouping and visualization
of GPCRs using Kernel
GTM
As stated in previous chapters, the grouping of GPCRs into types and sub-
types according to the amino acid symbolic sequences that describe them can
provide useful insights for the design of targeted pharmacological drugs. The
understanding of this grouping structure would benefit from its low dimensional
visual representation. Unfortunately, standard clustering techniques are of lit-
tle use for the grouping of symbolic sequences. Kernel methods can bypass this
limitation through the definition of kernels that appropriately describe similar-
ity and dissimilarity between sequences. Therefore, our target is the definition
of a kernel method for the simultaneous grouping and visualization of symbolic
sequences. We also want this method to be grounded on sound theoretical
foundations, and to have the ability to estimate the most adequate values for
its constituting parameters.
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4.1 Kernel Generative Topographic Mapping
The Generative Topographic Mapping (GTM) [4] is a non-linear latent variable
model of the manifold learning family, with sound foundations in probability
theory. It performs simultaneous clustering and visualization of the observed
data, through a non-linear and topology-preserving mapping from a visualiza-
tion latent space in in RL (with L being usually 1 or 2 for visualization purposes)
onto the RD space in which the observed data reside. The mapping that gener-
ates the embedded manifold takes the form:
y =Wφ(u), (4.1)
where u is an L-dimensional point in latent space, W is the matrix that gen-
erates the mapping, and φ consists of S basis functions φs(radially symmetric
Gaussians in the standard model for continuous data). To achieve computa-
tional tractability, the prior distribution of u in latent space is constrained to
form a uniform discrete grid of M centres, analogous to the layout of the SOM
units, in the form of a sum of delta functions:
p (u) =
1
M
M∑
m=1
δ (u− um) , (4.2)
where M is the number of nodes in the grid.
This way defined, the GTM can also be understood as a special case of
a Gaussian mixture model that is adapted to provide high-dimensional data
visualization. Each component m in the mixture defines the probability of an
observable data point x given a latent point um and model:
p(x | um,Θ) =
(
β
2pi
)D
2
exp
{
−
β
2
‖x− ym‖
2
}
(4.3)
where D is the dimensionality of the data space, and ym =Wφ (um).
The set of adaptive parameters Θ is constituted by W and the common
inverse variance β. A density model in data space is therefore generated for
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each component m of the mixture, which, assuming that the observed data set
X consists of N independent, identically distributed (i.i.d.) data points xn,
leads to the definition of a likelihood in the form:
L (W,β) =
N∏
n=1
1
M
M∑
m=1
p (xn | um,W, β) (4.4)
However, it is more convenient to work with the log-likelihood function:
L (W,β) =
N∑
n=1
ln
{
1
M
M∑
m=1
p (xn | um,W, β)
}
(4.5)
The adaptive parameters of the model are usually optimized by Maximum
Likelihood (ML) using the Expectation-Maximization (EM) algorithm [11]. In
the E-step, we use the current values of the parameters W and β to evaluate
the posterior probability, or responsibility, which each component m takes for
every data point xn, which, using Bayes’ theorem, is given by
Rnm ≡ p (m | xn) =
p (xn | m)∑
j p (xn | j)
, (4.6)
in which the prior probabilities P (m) = 1
K
have cancelled between numerator
and denominator. Using 4.3, we can rewrite this in the form
Rnm =
exp
{
−β2 ‖ xn − ym ‖
2
}
∑
m exp
{
−β2 ‖ xn − ym ‖
2
} (4.7)
Then in the M-step we use the responsibilities to re-estimate the weight matrix
W by solving the following system of linear equations:
(
ΦTGΦ
)
WTnew = Φ
TRX, (4.8)
which follow by maximization of the expected complete-data log likelihood. In
4.8, Φ is a K × M matrix with elements Φmj = Φj (um), X is an N × D
matrix with elements xnk, R is a K × N matrix with elements Rnm, and G
is a K ×K diagonal matrix with elements. The inverse variance parameter is
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also re-estimated in the M-step using Gmm =
∑
nRnm. The inverse variance
parameter is also re-estimated in the M-step using:
1
βnew
=
1
ND
N∑
n=1
M∑
m=1
Rnm ‖Wnewφ (um)− xn ‖
2 (4.9)
We can initialize the parameters W so that the GTM model initially ap-
proximates PCA. To do this, we first evaluate the data covariance matrix and
obtain the eigenvectors corresponding to the q largest eigenvalues, and then we
determine W by minimizing the sum-of-squares error between the projections
of the latent points into data space by the GTM model and the corresponding
projections obtained from PCA. The value of β−1 is initialized to be the larger
of either the q + 1 eigenvalue from PCA (representing the variance of the data
away from the PCA sub-space) or the square of half of the grid spacing of the
PCA-projected latent points in data space.
The main advantage of the GTM over the SOM model is that the former
generates a density distribution in the input data space so that the model can be
described and developed within a principled probabilistic framework. An exam-
ple of development of the GTM is the use of a Bayesian approach to automatic
regularization and smoothing of the resulting mapping. As part of this process,
the GTM learning parameters calculation is grounded in a sound theoretical
basis. The GTM also provides the well-defined objective function of equation
4.5, whereas the SOM training does not involve the minimisation of any error
function; its maximisation using either standard techniques for non-linear opti-
misation or the EM-algorithm has been proved to converge, unlike in the case
of the SOM.
4.1.1 Kernelization of the GTM
Kernelization is a method originally defined for Support Vector Machines (SVM)
which could be used to develop generalizations of any algorithm that could be
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cast in dot product terms. The idea is that a method formulated in terms of
kernels can use the one that best suits the problem and data type at hand. With
this purpose, we define kernel-GTM (KGTM). It takes advantage of the original
GTM functionalities to achieve clustering and visualization of a wider variety
of data types [41]. Moreover, GTM lacks the ability to handle more structured
data, such as strings.
4.1.2 The KGTM model and its application to sequence
analysis
Let us consider the problem of embedding GPCR sequences in a high-dimensional
space in such a way that their relative position in that space reflects their similar-
ity and that the inner product between their images can be computed efficiently.
The first decision to be made is what similarity notion should be reflected in the
embedding, or, in other words, what features of the sequences are informative
for the task at hand.
The meaning of similarity in biological applications is related to both func-
tional similarity and symbolic sequence similarity, the latter measured by the
number of insertions, deletions and symbol replacements. Measuring sequence
similarity should therefore give a good indication about the functional similarity
that bioinformatics researchers would like to capture.
The similarity between two sequences is usually evaluated by first aligning
the sequences (or parts of them) and then deciding whether their alignment is
more likely to have occurred because the sequences are related or just by chance.
When two sequences are compared, the basic mutational processes under
consideration are substitutions, which change residues in a sequence, and inser-
tions and deletions, which add or remove amino acids in the sequence. Insertions
and deletions are together referred to as gaps. Natural selection has an effect on
this process by screening the mutations, so that some types of changes remain
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throughout evolution and appear more often than others [14]. In order to have
some control over the number of gaps, their size, position, etc., usually gap
penalties are introduced. Then, the score, used to judge the correctness of the
alignment, is modified accordingly to allow the number of gaps to be limited.
The total similarity score assigned to an alignment will be a sum of terms for
each aligned pair of residues, plus terms for each gap. In a probabilistic inter-
pretation, this corresponds to the logarithm of the relative likelihood that the
sequences are related, compared to being unrelated. Informally, identities and
conservative substitutions are expected to be more likely in alignments than
appearing by chance and, therefore contribute positively to the similarity score.
On the contrary, non-conservative changes are expected to be observed less fre-
quently in real alignments than expected by chance, and so they contribute
negatively.
In order to gauge similarity for each aligned residue pair, we will derive
substitution scores from our probabilistic model. The scores can be arranged in
a matrix. For the protein sequences analyzed in this thesis, consisting on arrays
of symbols from a 20 amino acid alphabet, a 20 × 20 matrix can be calculated,
known as score matrix or substitution matrix.
A kernel function can be thought of as a measure of similarity between
sequences. Different kernels correspond to different notions of similarity, and can
lead to discriminative functions with different performance. The kernel function
designed to analyze GPCRs with KGTM is a variation on that described in [41],
based on the mutations and gaps between sequences:
K (x, x′) = exp
{
ν
pi (x, x′)√
pi (x, x) pi (x′, x′)
}
(4.10)
where x and x′ are two sequences and ν is a prefixed parameter; pi (.) is a
score function commonly used in bioinformatics and expressed as: pi (x, x′) =∑
r s (xr, x
′
r) − γ, where xr and x
′
r are the r
th residue in the sequences. The
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value of s (xr , x
′
r) can be found in a mutation matrix [14] and γ is a gap penalty
(usually the number of gaps in sequences). A normalization factor, defined as
the geometric mean of the maximum scores for each of the sequences, is used in
the kernel function instead of the sum used in [41].
4.1.3 The KGTM algorithm
The kernel trick allows the observed data X to be implicitly mapped into a high-
dimensional feature space H via a nonlinear function: x 7−→ ψ (x). A similarity
measure can then be defined from the dot product in space H as follows:
K
(
x, x
′
)
=
〈
ψ (x) , ψ
(
x
′
)〉
(4.11)
K is a kernel function that should satisfy Mercer’s condition [54]. It allows
us to deal with learning algorithms using linear algebra and analytic geometry.
In general, this method deals with data in the high-dimensional dot product
space H , usually known as feature space.
The use of kernel trick avoids the explicit estimation of ψ, whose dimension
is usually unknown (or even infinite).
The kernelization of GTM can be implemented by redefining equation 4.3 in
feature space as:
p (ψ (x) | um,Θ) =
(
β
2pi
)D
2
exp
{
−
β
2
‖ψ (x)− ym‖
2
}
(4.12)
Note that the prototypes ym are now defined in the feature space and not
in data space, as originally. In most cases, the term ‖ψ (x) − ym‖
2 cannot be
directly evaluated, given that the function ψ (·) is usually unknown. However,
this term can be also expressed as follows:
‖ψ (x)− ym‖
2 = 〈ψ (x) , ψ (x)〉+ 〈ym, ym〉 − 2 〈ψ (x) , ym〉 (4.13)
Here, we assume that, as in KPCA, ym can be expanded on the training
data in the feature space. That is, ym = Ψwm , where Ψ is a D × N -matrix
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of vector columns Ψ (xn), n = 1..N , and wm a weight vector. With the aim
of preserving the topology, we correlate the weight vector to the latent space
by wm = Λφm, where Λ is an adaptive weight matrix and φm = φ (um) is the
set of radial basis functions typically used by GTM. Therefore, equation 4.13
becomes:
‖ψ (x)− ym‖
2 = Jmn = Knn + (Λφm)
T
KΛφm − 2knΛφm (4.14)
where K is a kernel matrix with elements Knn′ = 〈ψ (xn) , ψ (xn′ )〉, and row
vectors kn . Thereby Jmn is expressed in terms of the kernel matrix, making the
definition of function ψ (·) unnecessary. The adaptive parameters of the model
are now Λ and β , which can be optimized by ML using EM, as in GTM. The
likelihood of the model is formulated as follows:
L (Λ, β) =
N∏
n=1
1
M
M∑
m=1
p (ψ (xn) | um,Λ, β) (4.15)
Following the usual EM algorithm, we are specially interested in one of the
results of the expectation step of EM, namely the estimation of the posterior
distribution Rmn = p (um | ψ (xn) ,Λ, β) , defined as:
Rmn =
p (ψ (xn) | um,Λ, β)∑M
m
′=1 p (ψ (xn) | um′ ,Λ, β)
(4.16)
Rmn measures the degree of responsibility (probability) of a point um in the
latent space for the generation of a ψ (xn) GPCR data subsequence. In turn,
each Rmn is an element of a M ×N responsibility matrix R.
In the maximization step we use equation 4.15 as the optimization function
to determine the parameters Λ and β, which results in the following expressions:
ΛT =
(
ΦTGΦ
)−1
ΦTR (4.17)
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1β
=
1
ND
N∑
n=1
M∑
m=1
RmnJmn (4.18)
The initial values for the parameters of KGTM are selected using KPCA (a
procedure which is inspired in the PCA-based initialization of parameters for
the standard GTM).
4.2 The GPCR dataset
The dataset analyzed in this thesis and used to assess the performance of KGTM
in the grouping and visualization of GPCR consists of 232 amino acid sequences
obtained from de public GPCR database and information system GPCRDB [26],
corresponding to seven types (type 3 was not analyzed as it was not included
in the GPCRDB database) belonging to the family C.
The GPCRDB stores three kinds of experimental data: sequences, mutation
data and ligand binding data. In this database, sequences had been already
downloaded previously aligned.
Each position in a sequence is called a residue, which in turn may be one of
20 possible amino acids (See table 4.1). Each amino acid has a standard one-
letter code, and a sequence is therefore represented by a combination of these
letters.
The number of residues by sequence (that is, the data dimensionality) in the
analyzed dataset is 253. Table 4.1 shows the nomenclature for each amino acid,
and the codes for the complete dataset are shown in table A.1. They are listed
so that any other researcher interested in replicating our results could do so in
an informed way. Two examples of sequences are shown in table 4.2 in FASTA
format [34].
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Amino acid name Letter Amino acid name Letter
Alanine A Leucine L
Arginine R Lysine K
Asparagine N Methionine M
Aspartate D Phenylalanine F
Cysteine C Proline P
Glutamate E Serine S
Glutamine Q Threonine T
Glycine G Tryptophan W
Histidine H Tyrosine Y
Isoleucine I Valine V
Table 4.1: List of the 20 possible amino acids that can have a residue.
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Header Sequence
ts1r3−mouse RPKFLAWGEPVVLSLLLLLCLVLGLALAALGLSLVQA
SGGSQFCFGLICLGLFCLSVLFPGRPSSASCLAQQPM
AHLPLTGCLSTLFLQAAETFVESELPLSWNWLCSYLR
GLWAWLVVLLATFVEAALCAWYLIAFPPEVVTDWSLP
TEVLEHCHVRSLGLVHITNAMLAFLCFLGTFLVQSQP
YNRARGLTFAMLAYFITWVSFVPLLANVQVAYCALGI
LVTFHLPKCYVLLWLPKLNTQEFFLGRNAKK
q7pfp4−anoga −FAFYTVVILSLIGIGISVLFLGLNLRF− −−−−ST
ITVCGCMLVYTATILLGLDHSTL− −−−−−STICMRIY
FLSAGFSLAFGSMFAKTFRVYRIFTH− −−− −LISVIG
ALLLVDAFVVSFWMAAD− −−−−−−−−−−
−− −−−−−−−−−−−−−−−C−−−WLG
MLYAYKGLLLLVGVYMAWQTRNVK−−NDSQ
YIGISVYSV VITSASVVVLANLLYERIITAG
FVLISTTATLCLLFLPKI−−−−−−−−−−−−−
Table 4.2: Two sequences from the dataset. The first column represents the
ID or header of the sequence and the second one represents the inner sequence.
The gaps are represented by ’−’.
4.3 KGTM grouping and visualization of GPCRs
The KGTM is a fully unsupervised model, that is, it not use any GPCR type
or subtype label, even if known, as part of the data modelling process. The
labelling of individual sequences is accomplished a posteriori, in order to assess
the sequence grouping and visualization results.
The visualization of the GPCR sequences in the low-dimensional, latent
representation space of the KTGM is accomplished through the use of the mode-
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projection, defined as:
mmode = argmax
m
Rmn (4.19)
where Rmn is the responsibility (probability) of a point um in the latent space
of KGTM for the generation of of the feature space-transformed sequence. Note
that using equation 4.19 entails selecting that latent point for which the re-
sponsibility for a given sequence is maximum. This could be understood as a
summary measure (winner takes all) according to which we can assign a given
sequence to a specific latent point (or cluster representative). Even if only this
summary measure is used to simplify the visualization procedure, we should not
forget that there is still a non-zero probability of a given sequence belonging to
any other cluster (latent point in the KGTM grid).
The basic visualization results using KGTM for the analyzed GPCR dataset
are shown in figure 4.1. Seven types of family C have been modelled and and
their sequences assigned to clusters in the KGTM representation map according
to equation 4.19.
Overall, a clear separation between many of the GPCR types can be ob-
served. Many receptor types occupy a rather differentiated area on the map,
showing little overlapping. Thus, mGlu receptors (type 1), GABA-B (4), and
Taste (8) are clearly differentiated from the rest of types, the latter showing
significant overlapping between them. This overlapping can be, in part, phar-
macologically explained. Odorant, Vomeronasal and Pheromone types, which
present a high degree of overlapping, are related with the sense of smell. On
the other hand, the obtained mixing of these receptors with the Calcium Sens-
ing receptor is consistent with the branches distribution observed in published
phylogenetic tree analyses [47] (see below for comparison of KGTM and phylo-
genetic tree methods of classification). Finally, the mixing between some mGlu
receptors and receptors associated to smell sense requires further analyses (a
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putative explanation will be given below).
Figure 4.1: KGTM-based data visualization on a 10 × 10 representation map
using the mode projection as described in the text. Left) Pie charts represent
individual latent points and their size is proportional to the ratio of sequences
assigned to them. Each portion of a chart corresponds to the percentage of
sequences belonging to each type. Right) The same map without sequence ratio
size scaling, for better visualization. Labels: 1: Metabotropic glutamate, 2:
Calcium sensing, 4: GABA-B, 5: Vomeronasal, 6: Pheromone, 7: Odorant, 8:
Taste.
The mode-projection is an intuitive form of visualization that, as previously
mentioned, sacrifices detail in favour of clarity. By using only the maximum of
the responsibilities in R, though, it disposes of much of the rich information that
might be contained in this matrix of probabilities. There are different ways of
visually representing this information. One of them is the display of full maps
of probability Ri, for a given sequence i.
Sequences clearly ascribed to a type are likely to have their responsibilities
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concentrated in only a few modes (latent points), whereas the probabilities of
sequences without clear type ascription may be more evenly spread across the
map.
We may be also interested in the responsibilities of all sequences of a given
type at once. In this case, we would aim to assess if each type has its respon-
sibilities located in a well-defined area of the map or not. For this, we use the
cumulative responsibility of the sequences that belong to a given type c, which
is defined as a vector CRc =
∑
{n∈c}Rmn, for m = {1, ..,M}.
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Figure 4.2: Visualization of the global CR (on the vertical axis) of the data set
on the representation map. For better appreciation, several viewpoints of the
map are provided.
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This takes us to the possibility of displaying the cumulative responsibility
of all sequences in the database. With this map of probability, the existence
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of CR peaks and valleys can be explored. The latter are likely to define the
boundaries between types.
The global CR is displayed in figure 4.2, whereas figure 4.3 provides the
visualization of the CRc for the seven analysed types of the family C. Consistent
with the type specific representations in figure 4.3, several local maxima are
shown to correspond to each type, which could be an indication of heterogeneity
within the types. Some deep valleys of probability can be seen in the central
parts of the map in figure 4.2, drawing clear boundaries between the types
represented in the periphery of the map and those around its center. Some
amongst the latter are the ones with a higher level of mixing and would merit
further investigation.
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Figure 4.3: CRc representation maps for all GPCR family C types. Labels:
1: Metabotropic glutamate, 2: Calcium sensing, 4: GABA-B, 5: Vomeronasal,
6: Pheromone, 7: Odorant, 8: Taste. Type 1 (Metabotropic glutamate), the
most populated, is well-defined on the top-right corner of the map; type 4
(GABA-B), also isolated and unmixed in the left hand-side of the map; type
6 (Pheromone), strongly focused on the bottom right corner of the map, but
partially overlapping with right: type 7 (Odorant). The layout corresponds to
that of figure 4.1, although with its viewpoint slightly displaced to the left, to
provide some perspective.
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Our results are consistent with early classification studies using other tech-
niques such as Hidden Markov Models [48], thereby validating the present
methodology. Importantly, the KGTM mapping reveals mixing between some
receptor types, suggesting its possible applicability to the study of heterodimer-
ization [3] between receptors. Receptor heterodimerization has been confirmed
experimentally for a number of receptors. This finding paves the way for new
strategies in drug discovery research providing a conceptual framework for the
rational combination of drugs. KGTM may help in the exploration of receptors
susceptible of heterodimerization and thus be useful in the quest of more potent
and safer drugs.
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4.3.1 Zooming into the mGlu receptor GPCR subtype
As described in subsection 2.3.1, the mGlu receptors, widely distributed through-
out the CNS, play a relevant role in the regulation of cell excitability and synap-
tic transmission.
They are divided into three groups (I, II, III) including eight subtypes:
Group-I: mGlu1, mGlu5; Group-II: mGlu2, mGlu3; Group-III: mGlu4, mGlu6,
mGlu7 and mGlu8.
The mode projection-based KGTM visualization of the mGlu receptors in
our dataset is displayed in figure 4.4. It reveals the distribution of the eight
different subtypes extracted from the GPCRDB dataset.
It is worth mentioning that in the primary data set the mGlu7 subtype was
absent. Instead, a new subtype denoted as mGluLike was present. It may
be assumed that the mGluLike subtype includes receptors that are classified
as mGlu receptors by the GPCRDB program but without a fully true genetic
adscription.
Strikingly, KGTM separates quite well each of the eight subtypes within the
mGlu receptor type. Further detail of the mapped location of each subtype can
be appreciated in the display of figure 4.4.
It is worth mentioning that the plot of mGlu subtypes displayed in figure 4.4
has been done on the KGTM model obtained previously for family C. In other
words, the KGTM model was not trained again on the mGlu subset; instead,
the other types were made “silent” and sequences were labelled accordingly with
their mGlu receptor subtype identity.
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Figure 4.4: Mode projection of the type 1 mGlu receptor subtypes. Labels: 1:
mGlu1, 2: mGlu2, 3: mGlu3, 4: mGlu4, 5: mGlu5, 6: mGlu6, 8: mGlu8, 9:
mGluLike. The analysed dataset has no mGlu7 subtype cases. There is a visible
separation of the subtypes in three main groups, according to the amino acid
sequence similarity, agonist pharmacology and the signal transduction path-
ways to which they couple: group I (mGlu1, mGlu5), group II (mGlu2, mGlu3,
mGluLike) and group III (mGlu4, mGlu6, mGlu8)
According to this visualization, the mGlu receptor sequences of subtype
9 corresponding to mGluLike, assigned to cluster 83 are very homogeneous.
They include the subtypes mGluLike2 and mGluLike3 and are well-located
between mGlu2 and mGlu3. On the other hand, the mGluLike groups assigned
to clusters 98 and 80 are quite far from Type 1- mGlu receptors but very close to
the Types 5 (Vomeronasal), 6 (Pheromone) and 7 (Odorant) (See figure B.8 in
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Appendix B for complete detail), taking into account their neighbourhood. This
suggests that some GPCRDB assignments of mGluLike receptors to the mGlu
group might be incorrect, and that they might in fact be smell sense receptors.
This is only a hypothesis and would require further testing.
4.4 KGTM and phylogenetic tree representations
of GPCR
4.4.1 From protein sequences to phylogenetic trees
Generally speaking, a phylogenetic tree is a dendogram-like graphical represen-
tation of the evolutionary relationship between taxonomic groups which share
a set of homologous characters. In biology, the term homology, according to
Fitch [19], is the relationship between two characters that have descended, usu-
ally with divergence, from a common ancestral character. These characters
can be any genic (gene or protein sequence), structural (i.e. morphological) or
behavioural feature of an organism.
Cladograms, a particular case of dendograms, are branched diagrams that
illustrate patterns of relationships, where the branch lengths are not necessarily
proportional to the evolutionary time between groups [17]. A phylogenetic tree
can thus be seen as a specific type of cladogram where the branch lengths can
represent evolutionary time between groups.
Phylogenetic trees can represent evolutionary relationships by rooted or un-
rooted binary trees [43]. Figure 4.5 shows the topology of an unrooted and a
rooted phylogenetic tree which consists of vertices of degree 1 called leaves and
unlabeled internal vertices of degree 3. Formally, we say that a vertex v1 is a
descendant of another vertex v, if v lies on the path between v1 and the root
vertex. Edges adjacent to a leaf are called pendant edges, while all other edges
are internal. On the other hand, the edge length is the distance between nodes
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(can represent the evolutionary time) and the shape of an unrooted tree is ob-
tained by dropping the labeling of the leaves of a binary phylogenetic tree. In
our work, the leaves correspond to the GPCR protein sequences.
1
c
d
b
a a b c d
(A) (B)Leaves
Vertices
Root vertex
Internal edge
Pendent edge
Figure 4.5: Topology and terminology of phylogenetic trees: (A) Unrooted
binary tree with four leaves (B) Rooted binary tree with four leaves
In order to create a phylogenetic tree, we need to know the evolutionary
distance between the protein sequences. Distance methods aim to construct an
all-to-all matrix from the set of sequences describing the distance between each
sequence pair. Often, the metric is chosen to be the Euclidean distance. These
methods are based on the idea of grouping together those two sequences that are
closest first, recalculating the distances, and then grouping again in an iterative
process which stops when all the sequences have been grouped. Importantly,
the order in which the sequences are clustered determines the graph topology
[17].
As a result of the grouping procedure, the phylogenetic tree places the related
sequences close together under the same interior node, with the branch lengths
closely reproducing the observed distances between sequences.
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4.4.2 Interpretability and concordance with the KGTM
In this section, we explore the phylogenetic tree structure of the 232 GPCR
amino acid sequences already grouped and visualized using KGTM. With this,
we aimed to find whether the data structure revealed by KGTM properly reflects
the phylogenetic structure of the data.
In our experiments, phylogenetic trees were obtained using the Java align-
ment editor application Jalview 2.6.1 [60]. In this application, sequences are
introduced in FASTA format and the trees are calculated on the basis of a
measure of similarity between each pair of sequences in the alignment.
The BLOSUM62 scoring matrix [24] was used as the basis for the applica-
tion of the Unweighted Pair-Group Method with Arithmetic Mean (UPGMA)
algorithm [57], which examines the structure present in a similarity matrix and
builds the corresponding phylogenetic tree.
The BLOSUM62 (BLOcks of Amino Acid SUbstitution Matrix) is a scor-
ing system [15] to obtain the best sequences alignment based on the 20 × 20
BLOSUM 62 scoring matrix, which compares the sequences with no less than
62% divergence. During the process, every possible identity and substitution is
assigned a score based on the observed frequencies of such occurrences in align-
ments of related proteins. BLOSUM with high numbers are used for highly re-
lated sequences, while low numbers are used for distantly related proteins. Thus,
complete identities are assigned the most positive scores. Frequently observed
substitutions also receive positive scores and seldom observed substitutions are
given negative scores (See example in figure 4.6).
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Figure 4.6: A BLOSUM 62 scoring matrix example
The UPGMA algorithm can be summarized as follows [14]:
1. Initialisation:
• Define n clusters C1, ..., Cn, one for each sequence
• Initial tree T = {leave nodes}, all at height zero
2. Iteration:
• Define distance between cluster Ck and Cl as the average distance
between all pairs of sequences from each cluster:
δkl =
1
|Ck| |Cl|
∑
i∈Ck
∑
j∈Cl
d (i, j)
• Determine two clusters, k and l for which δkl is smallest.
• Define a new cluster Cm = Ck ∪ Cl and remove clusters Ck and Cl.
• Updating tree: add a node m with daughter nodes k and l to the
tree T and place it at height δkl2 .
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3. Termination:
• When only two clusters k and l remain place the root node at height
δkl
2 .
The pairwise distances which are visualized in the phylogenetic trees show
the relationships between the protein sequences in each GPCR group.
Ultimately, UPGMA yields a distance-based sequence clustering solution in
the same sense that KGTM provides one. There are radical differences between
them, though. UPGMA is strictly hierarchical in nature and proceeds agglom-
eratively. It means that once agglomerated, clusters cannot be partitioned any
longer throughout the procedure. This introduces a directional bias in the so-
lution. Also importantly, cluster assignments at each level of the tree hierarchy
are completely symmetrical; that is, the relative position of a sequence within
each cluster is arbitrary, which makes the direct interpretation of proximity not
too straightforward, specially for big trees.
On the other hand, KGTM (at least as presented in this thesis) is not hi-
erarchical or agglomerative in nature, which avoids any directional bias. Also,
its visualization map makes the assessment of proximity far more intuitive and
devoid of any symmetry-related artifacts.
In the comparative results reported in the following figures, and due to page
size limitations, phylogenetic trees can be only partially represented. The tree
parts displayed are those that contained the data associated to each KGTM
partial map. For the visualization of the complete phylogenetic tree, see figure
B.9 in appendix B and a summarized version of the tree is visualized in the
figure B.10.
The visual comparison of the phylogenetic tree with the KGTMmode projec-
tion of the data, confirms that the overall grouping structure is quite similar. For
example, figure 4.7 reveals that the sequences corresponding to type 1 grouped
by the tree in a way that is quite consistent with KGTM. See, for instances how
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the KGTM clusters 51 and 61, or 81 and 91 are also close together in the tree.
The same can be said about clusters 73, 83, and 93 which are contiguous in the
tree and understood by KGTM as a differentiated subgroup. Notice though that
the KGTM reveals a mixing of types 1 and 6 in cluster 81 that is by no means
obvious in the tree. This is, in fact an undesired effect of the tree branching
symmetry, which ocludes a direct assessment of this proximity. Clusters 80 and
98 have a very mixed nature, and only the latter is type 1-dominated. This is
clear in the tree, where both clusters can be seen in the neighbourhood of types
6 and 7. Type 8 can be seen in the neighbourhood of the type 1 tree location,
but its boundary-like location is far more obvious from the KGTM visualization.
This boundary-like type 8 (See figure 4.8, showing neighbouring relations
with types 1, 4 and 6) is pure in its composition, which is an indication that is
a more radically different type of GPCR. Interestingly, this is rather obscured
in the phylogenetic tree, where the locations associated to type 8 are separated
by locations assigned to types 1 and 6. Again, this may just be a byproduct of
branching symmetry that can only be assessed through detailed inspection of
the tree construction. The KGTM has also revealed some sub-structure within
this type, which is at least partially corroborated by the tree solution. This
KGTM sub-structure seems to separate the small clusters located at the top
of the KGTM map from those at the bottom (which correspond to two neatly
separated branches of the tree), with big cluster 56 somewhere in the middle.
The exception to this interpretation are the small clusters 36 and 39.
The KGTM visualization reveals that the GPCR sequences most radically
separated from the rest are those belonging to type 4 (see figure 4.9), also very
pure in its composition. This is neatly reflected in the phylogenetic tree, which
locates type 4 in very isolated branches, with type 8 as the only neighbouring
relation. Also, the clusters detected by KGTM are extremely coherent with the
three representation of the sequences assigned to them.
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Figure 4.7: Complete matched visualization of Type 1 including the KGTM
mode projections and the corresponding phylogenetic tree.
61
Figure 4.8: Complete matched visualization of Type 8 including the KGTM
mode projections and the corresponding phylogenetic tree.
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Figure 4.9: Complete matched visualization of Type 4 including the KGTM
mode projections and the corresponding phylogenetic tree.
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Finally, types 2, 5, 6 and 7 show a far more heterogeneous structure that
is also revealed in the tree. They are depicted in figures 4.10 to 4.13, and a
more detailed description is omitted here. Overall, the KGTM has been found
to provide a neat and simple, while very informative visualization, which is also
coherent with the detailed structure provided by the phylogenetic tree. Thus,
the KGTM could be recommended as a first-stage exploratory tool to which the
phylogenetic trees can provide a second-stage layer of finely detailed information.
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Figure 4.10: Complete matched visualization of Type 2 including the KGTM
mode projections and the corresponding phylogenetic tree.
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Figure 4.11: Complete matched visualization of Type 5 including the KGTM
mode projections and the corresponding phylogenetic tree.
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Figure 4.12: Complete matched visualization of Type 6 including the KGTM
mode projections and the corresponding phylogenetic tree.
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Figure 4.13: Complete matched visualization of Type 7 including the KGTM
mode projections and the corresponding phylogenetic tree.
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Chapter 5
Conclusions and future
work
The world of pharmacology is pointedly veering towards research based on the
data generated by pharmacogenomics and proteomics. More than half of the
existing drugs target just a handful of protein families and much research in the
area is currently devoted to analysing protein amino acid sequences.
The unravelling of the three-dimensional structure of GPCR’s would be key
for the understanding of its function and, therefore, for their applicability in
pharmacological research. This is a hard and mostly unresolved problem. On
the meantime, their amino acid sequences are easy to acquire and widely avail-
able. The grouping of GPCRs into types and subtypes based on the analysis of
these sequences is a building block towards their full characterization.
In this brief study, we have shown a kernel method of the manifold learning
family, namely the KGTM, which is capable of simultaneously revealing the
grouping structure of GPCRs while making the intuitive visualization of such
structure possible. This grouping problem is most commonly dealt with in the
field using phylogenetic trees. Phylogenetic trees are a widely used graphical
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tool in the field of proteomics, and they visually illustrate through hierarchical
dendograms the evolutionary closeness between sequences.
The results reported in the previous chapter and complemented by the ap-
pendices indicate that the KGTM yields a quite clear (and intuitively inter-
pretable) grouping structure for the GPCR Family C types. Several subtypes
occupy quite differentiated areas on the map, showing little overlapping. A few
of them, instead, have at least partially overlapping representations. We have
focused on one of these types, the metabotropic glutamate receptors, due to the
fact that they play important roles in regulating cell excitability and synaptic
transmission, being widely distributed throughout the central nervous system.
This makes them an important pharmacological target for a whole range of neu-
rological and psychiatric disorders. The KGTM has been shown to provide a
neat representation of the fine structure of these subtypes.
Importantly, the distribution of the groups revealed by the phylogenetic tree
of the analysed data shows striking coincidences with the groupings yielded
by KGTM, even, sometimes, down to the fine detail. This is a fine example
of how kernel methods for learning in structured domains can be useful in a
biological application context. The phylogenetic tree introduces a directional
bias in the grouping solution. Moreover, cluster assignments at each level of the
tree hierarchy are completely symmetrical, which makes the direct interpretation
of proximity not difficult to achieve. The KGTM visualization map makes the
assessment of proximity far more intuitive and devoid of any symmetry-related
artifacts.
The KGTM, as applied in this thesis, lacks hierarchical structure (although
hierarchies can be inferred and, to some extent, have been illustrated with some
of the analysed data). Thus, the KGTM, even if not a tool to replace phy-
logenetic trees, could confidently be recommended as a first-stage exploratory
tool to which the phylogenetic trees can provide a second-stage layer of finely
detailed information. In other words, both tools could complement each other,
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amplifying their individual advantages.
A straightforward extension of KGTM for future research is precisely its
definition within a hierarchical framework. For this, we could find inspiration
in previous work concerning similar models such as SOM [21], mixture models
[5], [61], [59], or even the own GTM [58]. The obtained hierarchical structure
could be compared to that provided by phylogenetic trees in a more principled
way.
In future research, KGTM might be used to help in the exploration of re-
ceptors with very heterogeneous grouping structure. This heterogeneity might
be a clue to their susceptibility towards heterodimerization, which could be use-
ful in the quest of more potent and safer drugs. The KGTM could also offer
the possibility of detecting receptors that are either misclassified (and thus be
used for database curation) or not assigned in the original database, a situation
commonly known as “receptor deorphanization”.
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Chapter 6
Thesis publications
1. Vellido A., Ca´rdenas M.I., Olier I., Rovira X. and Giraldo J. (2011) A
probabilistic approach to the visual exploration of G Protein-Coupled Re-
ceptor sequences. In Procs. of the 19th European Symposium on Artificial
Neural Networks (ESANN 2011), 233-238.
2. Ca´rdenas M.I., Vellido A., Olier I., Rovira X. and Giraldo J. (2011)A
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Appendix A
G-Protein coupled
receptors included in the
data set
Table A.1: Dataset observations obtained from GPCRDB [26].
G-Protein Coupled Receptors ID of the dataset
ts1r3−mouse q7pfp4−anoga q9bml7−drome grm1−caeel b2czc8−rat
a8whf3−drome a1z7f6−drome q52kv6−xenla grm4−mouse q2mhk9−danre
a1z7f4−drome q1lv89−danre grm2−human q4rxb9−tetng a3kqh9−danre
q8iw08−human q5i5d3−9tele a8dz74−danre ts1r2−ponpy a1imb8−caeel
q80z09−mouse a1imb9−caeel q62916−rat a8e7p8−danre q9qwk0−rat
ts1r3−felca q5i5d2−9tele q59hc2−human ts1r2−pantr a4phq8−danre
q16us0−aedae a3kqi0−danre grm6−rabit grm2−rat q75qw6−apime
b0vxf0−calja b2bh30−mouse a3kqh8−danre q0ef93−pig grm5−mouse
gpc6a−human a2sxs6−canfa q2mhk4−oryla a2t0n1−ponpy a8dz75−danre
Continued on next page
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o73637−fugru q6s738−apime b0uxy8−human q2mhk3−oryla ts1r2−mouse
q4sr46−tetng o73638−fugru q5i5d5−9tele o73639−fugru q172j2−aedae
a3qjy2−danre a2t0n3−papha gabr2−human a8k0f9−human a8wra6−caebr
q4s6z6−tetng casr−bovin q59hg8−human q8wtm9−caeel a0t301−danre
q93564−caeel q80za8−rat a3qjy6−danre q2mhk1−fugru a8e7u1−danre
a8dz73−danre q501x9−danre a3kql3−danre a8dz76−danre q9y133−drome
q5i5d6−9tele gpc6a−danre gpc6a−carau b1mt50−calmo q70gq8−drome
grm1−human q2mhk2−oryla o35271−rat a1l1t5−danre q9bml6−drome
q75qw7−apime q1lwn6−danre q4spr7−tetng a3qjx9−danre o35265−rat
grm1−mouse gabr2−mouse ts1r2−human o93552−carau b1axx0−mouse
a8wrn3−caebr grm−drome q8nha5−human q6pgj2−mouse q7q9v1−anoga
a8dz72−danre q9vps7−drome q2tkb6−ranca ts1r3−human o35267−rat
grm5−human q2mhl1−danre q5suj9−human v2r1−mouse ts1r2−cebpy
a8e7t9−danre grm4−macfa ts1r1−mouse casr−mouse q767k3−xenla
q2mhj9−fugru a8e7k1−danre q5i5d1−9tele q1lun9−danre o35266−rat
b3diw0−danre grm5−rat a8k5p7−human grm8−mouse q2mhk6−oryla
a0t303−danre q5suj8−human b0w5u1−culqu a7swz2−nemve q9bml5−drome
grm2−mouse o93558−carau q4t849−tetng casr−rat q1lv70−danre
a8wsb1−caebr q5i5d4−9tele o35268−rat gpc6a−rat q5tz45−danre
q8caf8−mouse o35269−rat grm6−mouse a3kqh5−danre a3qjy0−danre
a3fpk2−caeel a1z7f5−drome b0m0k7−human ts1r3−gorgo q8in24−drome
q292i3−drops b3ex10−sorar q5sul3−human b0uyj3−danre q05bd6−mouse
q5r970−ponab gabr2−rat o73640−fugru q5i5c3−9tele a6qpn0−bovin
a6h7g9−bovin ts1r2−canfa casr−human o93553−carau v2r26−mouse
a9jrj5−xentr a8k1r9−human a3kqm0−danre q20c73−drovi q1lv87−danre
b0r142−danre a3qjy1−danre q98uc5−chick ts1r2−rat q5i5d0−9tele
Continued on next page
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Table A.1 – continued from previous page
b0azm5−human q5i5c6−9tele a3qjx8−danre o35202−mouse q171a7−aedae
a7mbp0−danre ts1r3−pantr a3kq89−danre a4d0y3−human a0t300−danre
q4spr4−tetng b2rmx0−human q5i5c8−9tele q2mhk5−oryla q9psy1−carau
q2mhl2−danre b2re49−human a8k2d2−human ts1r2−gorgo b0v3c8−danre
q29lm3−drops a3qjy3−danre ts1r1−rat q4s834−tetng a1l4f9−human
grm6−human q29p68−drops a2ada0−mouse a9ra76−papan q90zf3−oncma
gpc6a−mouse a2t0n2−saisc b0s550−danre q6j164−human o73636−fugru
a3kqh6−danre q2mhk0−fugru ts1r3−canfa a3kpm6−danre q6unx3−ictpu
b0m0l0−human ts1r2−macmu q4va56−mouse grm1−rat q6mfx8−rat
gabr1−human a8dz71−danre b0uxy7−human q4s813−tetng a8pzb3−bruma
grm4−rat a8k0g9−human ts1r3−rat csrl1−human o35190−mouse
grm8−rat q4s836−tetng q16ur9−aedae q4rjz9−tetng a4phq7−danre
grm8−human grm4−human q9v3q9−drome ts1r1−human q0qds1−macfa
q4rnj1−tetng a3qjy4−danre q98uc6−chick a3kql9−danre q8mxu2−caeel
q2mhj8−fugru a3kqh7−danre q20073−caeel a3kqm9−danre ts1r2−saisc
a3qjy5−danre ts1r2−papha q5i5c7−9tele q3u5h1−mouse a8dz77−danre
q4sfl1−tetng q5i5c9−9tele q98uc4−chick q5ee43−macfa q5i5c5−9tele
gabr1−mouse q7pme5−anoga q1lv86−danre b3dib3−danre q53em0−human
grm6−rat a8kbc6−xentr q6pat5−mouse
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Appendix B
KGTM visualization of
GPCR Family C types
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Figure B.1: Type 1 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
81
2 4 6 8 10
2
4
6
8
10
MAP with "unit size" scale
2 4 6 8 10
2
4
6
8
10
MAP without "unit size" scale
Figure B.2: Type 2 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
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Figure B.3: Type 4 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
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Figure B.4: Type 5 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
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Figure B.5: Type 6 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
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Figure B.6: Type 7 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
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Figure B.7: Type 8 data visualization on a 10× 10 KGTM representation map,
using the mode projection.
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Figure B.8: General hierarchical visualization of GPCR Family C types, includ-
ing detailed subtyping of mGlu receptors.
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Figure B.9 shows the complete phylogenetic tree representation of the GPCR
family C data analysed in this thesis. The colors in the tree are automatically
generated by the software. Same color is assigned to close leaves (sequences) and
branches (groups of sequences) of the tree, according to the evolutive distance
between sequences. This distances are the numbers attached to the branches.
The software also automatically plots a red line which establishes the depth from
which the color grouping starts. Individual sequences in the leaves of the tree
are labelled according to three items: their ID , the family and the type (e.g.,
sequence ts1r3 mouse 003 001 indicates ID: ts1r3 mouse; family: 003 (C); and
type: 001).
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Figure B.9: The figure has been split due to space limitations. - continues on
the next page -
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Figure B.10: The complete phylogenetic tree of figure B.9 is represented here
in a reduced format in which the lower branches have been merged. The labels
in the leaves are just representatives of the groups they summarize.
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